InsideTrading SEC Form 4 insider trades

Stocks

UPB Upstream Bio, Inc.

Healthcare · Market cap: $152.3M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $0 2022-Q2: bought $0, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $0 2023-Q1: bought $0, sold $0 2023-Q2: bought $0, sold $0 2023-Q3: bought $0, sold $0 2023-Q4: bought $0, sold $0 2024-Q1: bought $0, sold $0 2024-Q2: bought $0, sold $0 2024-Q3: bought $0, sold $0 2024-Q4: bought $48.0M, sold $0 2025-Q1: bought $0, sold $0 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $0, sold $0 2026-Q1: bought $0, sold $46.6K 2026-Q2: bought $0, sold $30.6K 2026-Q3: bought $0, sold $27.6K 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $48.0M) Plan or routine purchases (part of bought) Sold, below the line (largest quarter $46.6K)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$0
2022-Q2$0$0
2022-Q3$0$0
2022-Q4$0$0
2023-Q1$0$0
2023-Q2$0$0
2023-Q3$0$0
2023-Q4$0$0
2024-Q1$0$0
2024-Q2$0$0
2024-Q3$0$0
2024-Q4$48.0M$0
2025-Q1$0$0
2025-Q2$0$0
2025-Q3$0$0
2025-Q4$0$0
2026-Q1$0$46.6K
2026-Q2$0$30.6K
2026-Q3$0$27.6K
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$48.0M3 buy days
Sold$104.8K15 sell days
Net insider flow+$47.9Mnet buying · 5 years
Latest trade2026-09-16Sutherland Everett Rand
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-09-16 Sell Sutherland Everett Rand CEO 2,095 $5.49 $11.5K 1
2026-09-16 Sell Deykin Aaron Other C-suite 895 $5.49 $4.9K 1
2026-09-16 Sell GRAY MICHAEL CFO 853 $5.49 $4.7K 1
2026-09-16 Sell Houghton Adam Other C-suite 700 $5.49 $3.8K 1
2026-09-16 Sell Ambrose Allison General counsel 485 $5.49 $2.7K 1
2026-06-16 Sell Sutherland Everett Rand CEO 2,095 $6.10 $12.8K 1
2026-06-16 Sell Deykin Aaron Other C-suite 895 $6.10 $5.5K 1
2026-06-16 Sell GRAY MICHAEL CFO 853 $6.10 $5.2K 1
2026-06-16 Sell Houghton Adam Other C-suite 700 $6.10 $4.3K 1
2026-06-16 Sell Ambrose Allison General counsel 477 $6.10 $2.9K 1
2026-03-16 Sell Sutherland Everett Rand CEO 2,093 $9.29 $19.4K 1
2026-03-16 Sell Deykin Aaron Other C-suite 894 $9.29 $8.3K 1
2026-03-16 Sell GRAY MICHAEL CFO 852 $9.29 $7.9K 1
2026-03-16 Sell Houghton Adam Other C-suite 699 $9.29 $6.5K 1
2026-03-16 Sell Ambrose Allison General counsel 475 $9.29 $4.4K 1
2024-10-15 Buy Blavatnik Len 10% owner 1,175,000 $17.00 $20.0M 1
2024-10-15 Buy ORBIMED ADVISORS LLC Director 825,000 $17.00 $14.0M 2
2024-10-15 Buy Chimovits Erez Director 825,000 $17.00 $14.0M 2

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
Blavatnik Len 10% owner $20.0M $0 2024-10-15
Chimovits Erez Director $14.0M $0 2024-10-15
ORBIMED ADVISORS LLC Director $14.0M $0 2024-10-15
Sutherland Everett Rand CEO $0 $43.7K 2026-09-16
Deykin Aaron Other C-suite $0 $18.7K 2026-09-16
GRAY MICHAEL CFO $0 $17.8K 2026-09-16
Houghton Adam Other C-suite $0 $14.6K 2026-09-16
Ambrose Allison General counsel $0 $10.0K 2026-09-16

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2024-10-15 3 $48.0M 42 -1.7% (-1.0% raw)-59.3% (-55.1% raw)-55.5% (-63.3% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.